Mereo BioPharma (AgeTech UK) Biomed
Kinase inhibitors and other in pipeline for various, inclusing COPD. Mission is to provide new therapies to patients with chronically debilitating and life limiting rare diseases that have few, if any, other treatment options.
Technology:
AgeTech Companies
Investment Stage:
N/A
Employee Number:
N/A
Investor Type:
N/A
Number Of Exists:
N/A
Industry:
UK AgeTech 2020
Founded Date:
N/A
Funding Status:
N/A
Headquarters:
United Kingdom